Gemcitabine and Erlotinib Before and After Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery

NCT00733746 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

123

Enrollment

OTHER

Sponsor class

Conditions

Pancreatic Cancer

Interventions

DRUG: erlotinib hydrochloride
DRUG: gemcitabine hydrochloride
PROCEDURE: therapeutic conventional surgery

Sponsor

Alliance for Clinical Trials in Oncology

Collaborators

[object Object]
[object Object]
[object Object]